open access

Vol 5, No 6 (2004): Practical Diabetology
Review articles (submitted)
Published online: 2005-02-02
Get Citation

Immunological disturbances in diabetes

Małgorzata Szelachowska, Barbara Szepietowska
Diabetologia Praktyczna 2004;5(6):355-364.

open access

Vol 5, No 6 (2004): Practical Diabetology
Review articles (submitted)
Published online: 2005-02-02

Abstract

Immunological disturbances in diabetes are important patophysiological factors in development of diabetes type 1 as well as diabetes type 2. In diabetes type 1 immunological disturbances concern mainly autoimmune process. On the genetic background and environmental factors lymphocytes T lid to selective β cells destruction. These autoimmune abnormalities could be dividing on humoral — antibodies against β cells antigen and cellular, mainly cytokines produce by lymphocytes and macrophages. Particularly important in the clinical point of view are humoral immune markers. There can be use for evaluation of the risk to developing diabetes type 1, identification of patients with latent autoimmune diabetes in adults. Furthermore there are markers of b cell secretion capacity and could be apply for prediction use of insulin in group of patients with diabetes type 2. It is well established that insulin resistance and impaired insulin secretion are central to the pathogenesis of type 2 diabetes. In this type of diabetes immunological disturbances are not so particular and are mainly connected with chronic inflammation. It is well known, that insulin resistance as well as secretory function of β cells correlates with presence of inflammatory cytokines.

Abstract

Immunological disturbances in diabetes are important patophysiological factors in development of diabetes type 1 as well as diabetes type 2. In diabetes type 1 immunological disturbances concern mainly autoimmune process. On the genetic background and environmental factors lymphocytes T lid to selective β cells destruction. These autoimmune abnormalities could be dividing on humoral — antibodies against β cells antigen and cellular, mainly cytokines produce by lymphocytes and macrophages. Particularly important in the clinical point of view are humoral immune markers. There can be use for evaluation of the risk to developing diabetes type 1, identification of patients with latent autoimmune diabetes in adults. Furthermore there are markers of b cell secretion capacity and could be apply for prediction use of insulin in group of patients with diabetes type 2. It is well established that insulin resistance and impaired insulin secretion are central to the pathogenesis of type 2 diabetes. In this type of diabetes immunological disturbances are not so particular and are mainly connected with chronic inflammation. It is well known, that insulin resistance as well as secretory function of β cells correlates with presence of inflammatory cytokines.
Get Citation

Keywords

diabetes type 1; immunological disturbances; diabetes type 2; latent autoimmune diabetes in adults

About this article
Title

Immunological disturbances in diabetes

Journal

Clinical Diabetology

Issue

Vol 5, No 6 (2004): Practical Diabetology

Pages

355-364

Published online

2005-02-02

Bibliographic record

Diabetologia Praktyczna 2004;5(6):355-364.

Keywords

diabetes type 1
immunological disturbances
diabetes type 2
latent autoimmune diabetes in adults

Authors

Małgorzata Szelachowska
Barbara Szepietowska

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Diabetologia Kliniczna dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl